Close Menu
Home » NCI IP-Licensing Study Shows That Patent Age Influences Deal Probability

NCI IP-Licensing Study Shows That Patent Age Influences Deal Probability

Feb 25, 2009
Premium

This article has been updated from a previous version to clarify data from the study.

About half of all National Cancer Institute technology licenses are executed within three years of the technology's initial patent application date; while almost all licenses include technologies within eight years of the application date, according to the results of a recent NCI study on the influence of patent term on biomedical technology licensing.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

PLOS Papers Look at Gut Mycobacterium Abscessus, Preterm Birth Transcriptomics, More

In PLOS this week: Mycobacterium abscessus linked to gastric conditions, placental gene expression changes associated with preterm birth, and more.

All That Plastic in the Lab

The Guardian reports that UK universities are looking into ways to reduce labs' reliance on single-use plastics.

Garlic Helps, Too

People with certain gene variants tend to not like vegetables, particularly bitter ones, CNN reports.

Now Here

MIT's Technology Review reports on a company's genetic test that gauges an embryo's susceptibility to certain diseases.

Nov
13
Featured Webinar

Targeted Detection of MET and NTRK Oncogenic Variants in Routine Molecular Analysis

Sponsored by
Agena Bioscience

This webinar will discuss advances in detecting MET and NTRK variants in tumor samples, which can help clinicians determine the appropriate therapy for cancer patients.

Nov
18
Featured Webinar

Simultaneous Single-Cell DNA and Protein Sequencing in AML Samples

Sponsored by
Mission Bio

This webinar will outline the results of a study that performed integrative single-cell genome and cell surface protein expression profiling of adult acute myeloid leukemia (AML) cases. 

Nov
19
Featured Webinar

Digital PCR for Tag Copy Number Assessment in CRISPR-Edited Cell Lines

Sponsored by
Stilla

Fluorescent proteins or self-labeling tags are invaluable tools for studying protein dynamics in living cells using fluorescence microscopy. However, quantitative imaging requires physiological levels of expression of the target protein of interest (POI), especially when stoichiometric interactions of the POI need to be investigated.

Dec
02
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of   FLT3  and  CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

What's Popular?

In Cancer

  1. Thermo Fisher Launches Genexus Sequencing System to Support Local Deployment of NGS

    Premium

  2. Illumina Unveils Liquid Biopsy Version of TSO 500 Panel, Highlights Early User Validations

    Premium

  3. Illumina, Lexent Partner on NGS-Based Cancer IVD Kit

  4. Guardant Health Q3 Revenues Spike 181 Percent

  5. MDxHealth Revenues Down 35 Percent for Nine-Month 2019 Period

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.